United Steel soars after rejecting takeover approach

The stories you need to know in the market this morning                                                                                                                                                                                                                                                                                                                                                                                                                 August 14, 2023 *Together with (NASDAQ: AUVI) Good day, 360 – Here are our top investing ideas today – these setups look primed! Be the best prepared trader on the Street! X - Up over 28% in pre-market after takeover offer from Cleveland Cliffs (CLF) AGBA - Up over 48% in pre after reporting earnings, massive year over year revenue growth TSHA - Up over 30% in pre after reporting initial clinical data from first adult patient in phase ½ Rett Syndrome trial *A message on behalf of Applied UV, Inc. Applied UV, Inc (Nasdaq: AUVI) Our Hot Stock Idea🔥 today is AUVI, focused on the development and acquisition of technologies that address food security and air and surface pathogen reduction in the healthcare, hospitality and commercial markets. The Company just [announced]( a MAJOR EARNINGS BOMB: - Total revenues for the second quarter of 2023 of approximately $10.8 million, representing an 83.6% increase over the comparable period in 2022 - Gross profit grew to approximately $2.4 million, up 84.8% from $1.3 million in the comparable period in 2022. Today has all of the catalysts we would look for in a breakout for a stock trading under $1. If you are a small-cap, momentum trading junkie… then this is the type of day you live for! If you decide to trade this, do your due diligence. I encourage you to review the “investors” tab on Applied UV, Inc. (AUVI)’s [website]( and jump on their [email list]( to keep up with all their developments. *Sponsored by IA Media. Please see disclosures below. X - Up over 28% in pre-market after takeover offer from Cleveland Cliffs (CLF) United States Steel Corporation (X) produces and sells flat-rolled and tubular steel products primarily in North America and Europe. Over the weekend [it was announced]( that Cleveland Cliffs (CLF) had proposed to acquire U.S. Steel (X) for $17.50 per share in cash plus 1,023 shares of CLF stock, valuing the deal at $35 per share. X announced it had rejected the $7.3billion bid from CLF as it seeks ‘strategic alternatives’. X is gapping over 28% high in pre-market on the news while CLF is down 6%. $28.70 was resistance in the pre-market and now becomes a potential area of support. Above it, the first target for bulls is the pre-market high at $29.80. Beyond that, $31.20 and $34 come into play. Below $28.70 there is potential support at $28, $27.40, $26 and a gap to fill at $22.82. AGBA - Up over 48% in pre after reporting earnings, massive year over year revenue growth AGBA Group Holding Limited (AGBA) together with its subsidiaries provides wealth management and healthcare institution services in Hong Kong. AGBA [reported earnings late Friday]( with Q2 Revenue of $17M, Up 325% YoY. The stock traded up over 48% this morning on the news. The $1.24 area was resistance in the after-hours and has since acted as support in the pre-market. Above it, targets are $1.33, $1.40 and then the pre-market high of $1.46. Beyond that $1.50, $1.60, $1.68, $1.80, $1.93 and $2 come into play. Below $1.24, there is potential support at $1.20, $1.16, $1.10 and a gap fill to $0.87. TSHA - Up over 30% in pre after reporting initial clinical data from first adult patient in phase ½ Rett Syndrome trial Taysha Gene Therapies Inc (TSHA) is a gene therapy company that focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. This morning the [company reported positive clinical data]( from its first adult patient in its phase ½ Rett Syndrome trial. The phase 1/2 trial showed TSHA-102 was well-tolerated with no treatment-emergent serious adverse events (SAEs) as of six-week assessment and improvement in key efficacy. THSA also reported Q2 financial results [and announced]( a $150 million private placement financing. The stock was up over 30% in pre-market on the news. The $1 area was initially resistance post news and now becomes potential support. Above it, the first major target for bulls is the pre-market high at $1.16. Beyond that, $1.25, $1.30, $1.40, $1.50, $1.64 and $1.80 come into play. Below $1, there is potential support at $0.95, $0.92, $0.88 and a gap to fill at $0.7390. [Economic Calendar]( P.S. Make sure you text “RAGE” to (888) 404-5747 to get all of my latest HOT STOCK ideas! *This investment involves substantial risk. Please see full disclosure below, and detailed discussion of risks and atypical results.  Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull  *PAID ADVERTISEMENT. Raging Bull has been paid twenty five thousand dollars by IA Media who was compensated by a third party not affiliated with the Company for advertising Applied UV, Inc. from a period beginning on August 14 through August 15, 2023. The third party, Company, or their affiliates may own and likely wish to liquidate shares of the Company at or near the time you receive this advertisement, which has the potential to hurt share prices. This advertisement and other marketing efforts, including alerts, may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Applied UV, Inc, increased trading volume, and possibly an increased share price of Applied UV, Inc’s securities, which may or may not be temporary and decrease once the marketing arrangement has ended. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of the issuance of this advertisement, the owners of Raging Bull do not hold a position in Applied UV, Inc, though they reserve the right to buy or sell shares in the covered company at any time following the dissemination of this communication. FOR COMMERCIAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for commercial and informational purposes only. A portion of our business is engaged in the promotion, marketing, and advertising of companies including public companies. A portion of Raging Bull’s business model is to receive financial compensation to promote public companies, conduct investor relations advertising and marketing, and publicly disseminate information regarding public companies through our websites email, SMS, and push notifications among other methods of communication. This compensation is a major conflict of interest in our ability to provide unbiased reporting. Therefore, this communication should be viewed as a commercial advertisement only. Note, we periodically conduct interviews and issue stock alerts that we are not compensated for. These are purely for the purpose of company awareness, and to generate subscription revenues. We have not investigated the background of the hiring third party or parties. All material information contained in this advertisement is based on information generally available to the public, including information released to the public or filed by the Company with applicable regulators which public information is believed to be reliable and accurate. Nevertheless, Raging Bull cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. Never invest in any stock featured in this advertisement, on our site or emails unless you can afford to lose your entire investment. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is not currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. USE OF FORWARD-LOOKING STATEMENTS. Our advertisements including this advertisement and related emails, reports and alerts may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information in this advertisement, related emails, reports or alerts or on our website or media webpage. This information is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https:// www.sec .gov/edgar/searchedgar/companysearch TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. WE MAY HOLD SECURITIES DISCUSSED. Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233 Lee, NH 03861, United States